SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-16-000183
Filing Date
2016-08-04
Accepted
2016-08-04 16:07:09
Documents
15
Period of Report
2016-08-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-201608048xkdoc.htm 8-K 33005
2 PRESS RELEASE pdli-201608048xkex991.htm EX-99.1 251672
3 PRESENTATION pdli-201608048xkex992.htm EX-99.2 4928
4 INFORMATION SHEET pdli-201608048xkex993.htm EX-99.3 583471
5 pdllogo2016a05.jpg GRAPHIC 5218
6 slide1080416.jpg GRAPHIC 128548
7 slide2080416.jpg GRAPHIC 226525
8 slide3080416.jpg GRAPHIC 125819
9 slide4080416.jpg GRAPHIC 144776
10 slide5080416.jpg GRAPHIC 139934
11 slide6080416.jpg GRAPHIC 148228
12 slide7080416.jpg GRAPHIC 84194
13 slide8080416.jpg GRAPHIC 171809
14 slide9080416.jpg GRAPHIC 155848
15 slide10080416.jpg GRAPHIC 114418
  Complete submission text file 0000882104-16-000183.txt   2866072
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 161807437
SIC: 2836 Biological Products, (No Diagnostic Substances)